Another full-regimen HIV pill enters the market: Triumeq

August 22, 2014 - Project Inform.

Convenient options for treating HIV infection got a boost today as the new all-in-one pill called Triumeq was approved by the FDA. Triumeq is a full HIV regimen made up of the three drugs dolutegravir (Tivicay), abacavir (Ziagen) and lamivudine (Epivir). Dolutegravir is an integrase inhibitor while the other two drugs are NRTIs, also available as Epzicom. Four full-regimen pills are now available as HIV treatment: Triumeq, Stribild, Complera and Atripla.

This is the first all-in-one HIV pill approved by the FDA without Truvada (tenofovir/emtricitabine), which makes it a new choice for those with impaired kidney function. Continue reading…

 

like0

Do you get our newsletter?

admin's picture

Sign up for our monthly Newsletter and get the latest info in you in box.

seventh name

Mariatmejia's picture

Mariatmejia commented on CROI 2015

Mon, 3/2/2015 - 5:39pm

Mariatmejia's picture

Mariatmejia commented on CROI 2015

Mon, 3/2/2015 - 5:38pm

Mariatmejia's picture

Mariatmejia commented on CROI 2015

Mon, 3/2/2015 - 5:38pm

Learn about the importance of adherence, barriers to it, and tips to help you take your HIV drugs as directed, including finding support.

Get information on what drug interactions are, why it is important to recognize them, and what types of substances interact with HIV drugs.

The 2013 WRI meeting focused on creating enduring engagement of women in HIV research and care across the research spectrum. 

admin's picture

Join our community

Connect to our support community and share experiences with other women living with HIV.

Join now >

admin's picture

You Can Help!

Together, we can change the course of the HIV epidemic…one woman at a time!

Please donate now!>